$SSY
SUNLINK HEALTH SYSTEMS INC

2019 Q2 Form 10-Q Financial Statement

#000156459019019170 Filed on May 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q2
Revenue $10.90M $12.36M $12.21M
YoY Change -10.77% -7.87% -0.6%
Cost Of Revenue $4.230M $5.539M $3.906M
YoY Change 8.29% 724.26% -9.79%
Gross Profit $6.669M $6.822M $8.308M
YoY Change -19.73% -46.47% 4.37%
Gross Profit Margin 61.19% 55.19% 68.02%
Selling, General & Admin $6.107M $6.078M $7.380M
YoY Change -17.25% 4.45% 1.37%
% of Gross Profit 91.57% 89.09% 88.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $430.0K $367.0K $526.0K
YoY Change -18.25% -4.18% -2.59%
% of Gross Profit 6.45% 5.38% 6.33%
Operating Expenses $7.506M $7.310M $9.392M
YoY Change -20.08% 4.73% 0.56%
Operating Profit -$837.0K -$488.0K -$1.084M
YoY Change -22.79% -32.22% -21.45%
Interest Expense -$56.00K $63.00K -$57.00K
YoY Change -1.75% 12.5% -56.15%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$999.0K -$551.0K -$1.153M
YoY Change -13.36% -7.08% -62.07%
Income Tax $144.0K -$226.0K -$49.00K
% Of Pretax Income
Net Earnings -$2.221M $1.042M -$1.454M
YoY Change 52.75% -277.21% -39.62%
Net Earnings / Revenue -20.38% 8.43% -11.9%
Basic Earnings Per Share $0.15
Diluted Earnings Per Share -$317.9K $0.15 -$195.4K
COMMON SHARES
Basic Shares Outstanding 6.987M 6.987M 7.417M shares
Diluted Shares Outstanding 6.987M

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.742M $9.160M $3.456M
YoY Change 124.02% 158.68% -67.09%
Cash & Equivalents $7.742M $9.160M $3.456M
Short-Term Investments
Other Short-Term Assets $2.185M $2.664M $2.937M
YoY Change -25.6% -13.59% -28.37%
Inventory $2.016M $2.003M $1.854M
Prepaid Expenses
Receivables $4.715M $5.251M $4.823M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.66M $19.08M $13.11M
YoY Change 27.06% 31.74% -42.05%
LONG-TERM ASSETS
Property, Plant & Equipment $5.243M $5.488M $5.896M
YoY Change -11.08% -47.95% -42.7%
Goodwill
YoY Change
Intangibles $1.353M $1.383M $1.470M
YoY Change -7.96% -7.8% -7.37%
Long-Term Investments
YoY Change
Other Assets $1.165M $806.0K $885.0K
YoY Change 31.64% -16.82% 5.61%
Total Long-Term Assets $7.761M $7.982M $13.07M
YoY Change -40.6% -40.03% 2.76%
TOTAL ASSETS
Total Short-Term Assets $16.66M $19.08M $13.11M
Total Long-Term Assets $7.761M $7.982M $13.07M
Total Assets $24.42M $27.06M $26.18M
YoY Change -6.71% -2.63% -25.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.564M $1.527M $1.239M
YoY Change 26.23% 21.77% -21.13%
Accrued Expenses $4.010M $275.0K $290.0K
YoY Change 1282.76% -6.14% -55.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.836M $319.0K $255.0K
YoY Change 1012.16% 23.64% -96.2%
Total Short-Term Liabilities $8.410M $6.040M $4.851M
YoY Change 73.37% 14.29% -60.61%
LONG-TERM LIABILITIES
Long-Term Debt $127.0K $2.739M $2.803M
YoY Change -95.47% -4.33%
Other Long-Term Liabilities $134.0K $236.0K $340.0K
YoY Change -60.59% -22.37% 17.65%
Total Long-Term Liabilities $966.0K $3.749M $4.139M
YoY Change -76.66% -4.34% 211.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.410M $6.040M $4.851M
Total Long-Term Liabilities $966.0K $3.749M $4.139M
Total Liabilities $9.376M $9.789M $8.990M
YoY Change 4.29% 6.36% -34.11%
SHAREHOLDERS EQUITY
Retained Earnings $1.058M $3.210M $2.743M
YoY Change -61.43% -23.52% -36.74%
Common Stock $14.24M $14.24M $14.62M
YoY Change -2.61% -3.25% -17.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.04M $17.27M $17.19M
YoY Change
Total Liabilities & Shareholders Equity $24.42M $27.06M $26.18M
YoY Change -6.71% -2.63% -25.92%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q2
OPERATING ACTIVITIES
Net Income -$2.221M $1.042M -$1.454M
YoY Change 52.75% -277.21% -39.62%
Depreciation, Depletion And Amortization $430.0K $367.0K $526.0K
YoY Change -18.25% -4.18% -2.59%
Cash From Operating Activities -$910.0K -$661.0K $429.0K
YoY Change -312.12% 118.15% -170.33%
INVESTING ACTIVITIES
Capital Expenditures -$405.0K $223.0K -$359.0K
YoY Change 12.81% -19.78% -32.26%
Acquisitions
YoY Change
Other Investing Activities $0.00 $6.899M $13.00K
YoY Change -100.0% 1574.51% -97.59%
Cash From Investing Activities -$405.0K $6.554M -$346.0K
YoY Change 17.05% -32870.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -103.0K -59.00K -168.0K
YoY Change -38.69% -106.56% 20.0%
NET CHANGE
Cash From Operating Activities -910.0K -661.0K 429.0K
Cash From Investing Activities -405.0K 6.554M -346.0K
Cash From Financing Activities -103.0K -59.00K -168.0K
Net Change In Cash -1.418M 5.834M -85.00K
YoY Change 1568.24% 911.09% -88.67%
FREE CASH FLOW
Cash From Operating Activities -$910.0K -$661.0K $429.0K
Capital Expenditures -$405.0K $223.0K -$359.0K
Free Cash Flow -$505.0K -$884.0K $788.0K
YoY Change -164.09% 52.15% -1085.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
181000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
254000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6986855
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9160000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3456000
CY2019Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
5251000
CY2018Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
4823000
CY2019Q1 us-gaap Inventory Net
InventoryNet
2003000
CY2018Q2 us-gaap Inventory Net
InventoryNet
1854000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1096000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-720000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1348000
CY2019Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0
CY2018Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
40000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2664000
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2937000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
19078000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
13110000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20154000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19867000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14666000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13971000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5488000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5896000
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1383000
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1470000
CY2019Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
305000
CY2018Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
305000
CY2019Q1 ssy Assets Held For Sale Not Part Of Disposal Group Noncurrent
AssetsHeldForSaleNotPartOfDisposalGroupNoncurrent
0
CY2018Q2 ssy Assets Held For Sale Not Part Of Disposal Group Noncurrent
AssetsHeldForSaleNotPartOfDisposalGroupNoncurrent
4510000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
806000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
885000
CY2019Q1 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
2494000
CY2018Q2 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
7170000
CY2019Q1 us-gaap Assets
Assets
27060000
CY2018Q2 us-gaap Assets
Assets
26176000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1527000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1239000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
319000
CY2018Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
255000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2148000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1959000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
275000
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
290000
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1771000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1108000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6040000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4851000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-522000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1042000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1320000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-588000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2739000
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2803000
CY2019Q1 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
774000
CY2018Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
996000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
236000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
340000
CY2019Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3749000
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4139000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
3493000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
3673000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10745000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10947000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3210000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2743000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-177000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-177000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17271000
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17186000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27060000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26176000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q1 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000
CY2018Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000
CY2019Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6987000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7347000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6987000
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7347000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12361000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11333000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34719000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34990000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4931000
CY2018Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4806000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
14225000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
14068000
CY2019Q1 us-gaap Supplies Expense
SuppliesExpense
329000
CY2018Q1 us-gaap Supplies Expense
SuppliesExpense
327000
us-gaap Supplies Expense
SuppliesExpense
942000
us-gaap Supplies Expense
SuppliesExpense
958000
CY2019Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
865000
CY2018Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
778000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2858000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2702000
CY2019Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
155000
CY2018Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
154000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
458000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
463000
CY2019Q1 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
CY2018Q1 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
21000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
367000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
383000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1056000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-488000
CY2019Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2018Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
944000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2018Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-238000
CY2019Q1 us-gaap Interest Expense
InterestExpense
63000
CY2018Q1 us-gaap Interest Expense
InterestExpense
56000
us-gaap Interest Expense
InterestExpense
185000
us-gaap Interest Expense
InterestExpense
302000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-551000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-593000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1079000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
87000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-226000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-226000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-296000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-325000
CY2018Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-593000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-853000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
383000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1367000
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5000
us-gaap Net Income Loss
NetIncomeLoss
467000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-588000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
467000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139000
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.05
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.12
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.05
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.12
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.20
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.18
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.06
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.20
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6987000
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7417000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7203000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8564000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6987000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7417000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7203000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8632000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-517000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
867000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
813000
ssy Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
172000
ssy Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
689000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6899000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Sale Of Other Assets1
ProceedsFromSaleOfOtherAssets1
937000
us-gaap Proceeds From Sale Of Other Assets1
ProceedsFromSaleOfOtherAssets1
412000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6797000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1090000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
193000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3856000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
383000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2974000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
1000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-576000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5830000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5704000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6953000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3456000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10494000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9160000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3541000
us-gaap Interest Paid Net
InterestPaidNet
168000
us-gaap Interest Paid Net
InterestPaidNet
269000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
176000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 2. &#8211; Business Operations</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Business Operations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink Health Systems, Inc., through subsidiaries, owns businesses that provide healthcare products and services in certain markets in the southeastern United States. Unless the context indicates otherwise, all references to &#8220;SunLink,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221; and the &#8220;Company&#8221; refer to SunLink Health Systems, Inc. and our consolidated subsidiaries. References to our specific operations refer to operations conducted through our subsidiaries and references to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; and &#8220;us&#8221; in such context refer to the operations of our subsidiaries. Our business is composed of two business segments, the Healthcare Services segment and the Pharmacy segment. Our Healthcare Services segment subsidiaries own and operate an 84- bed community hospital and a 66- bed nursing home in Mississippi, an IT service company based in Georgia, and healthcare facilities, which are leased to third parties. Our Pharmacy segment subsidiary operates a pharmacy business in Louisiana with four service lines.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The business strategy of SunLink is to focus its efforts on improving the operations, services and profitability of its existing Healthcare Services and Pharmacy businesses while seeking to sell certain of its underperforming subsidiaries&#8217; assets.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 17, 2019, a subsidiary of the Company completed the sale of a nursing home and related real estate for $7,300 subject to adjustment for the book value of certain assets and liabilities on the sale date. The pre-tax gain on the sale was $2,136, which is also subject to adjustment for the book value of certain assets and liabilities on the sale date.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company has used a portion of the cash proceeds from recent dispositions of assets to pay down debt and certain other liabilities, and to repurchase common shares, including in tender offers completed in February and December 2017, and open market repurchases of its common shares in December 2018, and to make improvements to its Healthcare Services businesses. The Company may also use existing cash, as well as any net proceeds from future dispositions, if any, to, among other things,&nbsp;&nbsp;prepay debts, return capital to shareholders including through potential public or private purchases of shares, improve its existing businesses, make selective acquisitions of Healthcare Services and Pharmacy businesses and for other general corporate purposes. There is no assurance that any further dispositions will be authorized by the Company&#8217;s Board of Directors or, if authorized, that any such transactions will be completed or, if completed, will result in net cash proceeds to the Company on a before or after tax basis. The Company considers the disposition of business segments, facilities and operations based on a variety of factors in addition to under-performance, including asset values, return on investments, competition from existing and potential competitors, capital improvement needs, the prevailing reimbursement environment under various Federal and state programs (e.g., Medicare and Medicaid) and private payors, and other corporate objectives. The Company believes certain facilities in its Healthcare Services segment as well as its Pharmacy segment continue to under-perform, and the Company has engaged advisors to assist it in evaluating the possible sale of its Pharmacy business lines.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has repurchased 359,959&nbsp;&nbsp;common shares pursuant to a stock repurchase program announced on November 29, 2018, which authorizes the repurchase of a total of 750,000 common shares.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
661000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
545000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
278000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
867000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 12. &#8211; Economic Damages Claim</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.25%;"><font style="font-weight:normal;">The Pharmacy Segment subsidiary asserted claims for economic damages in connection with the Deepwater Horizon Settlement Program related to the event which occurred in 2010.&nbsp;&nbsp;In January 2018, these claims were settled and payments of approximately $944 (net of costs and attorneys&#8217; fees) were received. The net settlements are recognized as a gain in the Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) for the nine months ended March 31, 2018</font>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
529000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2018Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
750000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
359959
CY2019Q1 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
1726000
CY2018Q1 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
1923000
ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
5655000
ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
5294000
CY2019Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-336000
CY2018Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
8000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-383000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-513000
CY2019Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
2136000
CY2018Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-3000
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
2136000
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-9000
CY2019Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
433000
CY2018Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
433000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2018Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
300000
CY2018Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
450000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
372000
CY2019Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
390041
ssy Share Repurchase Average Price Per Share Paid
ShareRepurchaseAveragePricePerSharePaid
1.03
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45209000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14623000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18529000
us-gaap Operating Expenses
OperatingExpenses
35488000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
459000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29000
CY2018 us-gaap Operating Expenses
OperatingExpenses
44789000
CY2019Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5717000
CY2018Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5352000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
466000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
552000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
793000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29000
CY2018Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
305000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000
CY2019Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
166000
CY2018Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0
CY2019Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
201000
CY2018Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
219000
CY2019Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-189000
CY2018Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-189000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-296000
CY2019Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-37000
CY2018Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-37000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8113000
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2019Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14900000
ssy Net Operating Loss Carry Forwards Expire Period
NetOperatingLossCarryForwardsExpirePeriod
2023 through fiscal 2038
CY2018 ssy Tax Cuts And Jobs Act Change In Tax Rate Discrete Net Tax Benefit
TaxCutsAndJobsActChangeInTaxRateDiscreteNetTaxBenefit
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
ssy Tax Cuts And Jobs Act Of2017 Changes In Valuation Allowance Position
TaxCutsAndJobsActOf2017ChangesInValuationAllowancePosition
0
ssy Tax Cuts And Jobs Act Of2017 Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ProvisionalIncomeTaxExpenseBenefit
0
CY2018 ssy Additional Income Tax Expense Benefit
AdditionalIncomeTaxExpenseBenefit
40000
CY2017Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
296000
ssy Tax Cuts And Jobs Act Of2017 Accounting Complete
TaxCutsAndJobsActOf2017AccountingComplete
true
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000
CY2018Q1 us-gaap Assets
Assets
27791000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
813000

Files In Submission

Name View Source Status
0001564590-19-019170-index-headers.html Edgar Link pending
0001564590-19-019170-index.html Edgar Link pending
0001564590-19-019170.txt Edgar Link pending
0001564590-19-019170-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-10q_20190331.htm Edgar Link pending
ssy-20190331.xml Edgar Link completed
ssy-20190331.xsd Edgar Link pending
ssy-20190331_cal.xml Edgar Link unprocessable
ssy-20190331_def.xml Edgar Link unprocessable
ssy-20190331_lab.xml Edgar Link unprocessable
ssy-20190331_pre.xml Edgar Link unprocessable
ssy-ex311_6.htm Edgar Link pending
ssy-ex312_9.htm Edgar Link pending
ssy-ex321_8.htm Edgar Link pending
ssy-ex322_7.htm Edgar Link pending